Bixiye
P25R1-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Natiijooyinka Raadinta
Soo bandhiga 1521 - 1530 ee natiijooyinka 3688
Bixiye
QP112R1-20 Changes to Electronic Funds Transfer Processes
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
Zoryve™ (roflumilast) - Medicaid - Effective Date 02/01/2025
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Bixiye
Hyftor™ (sirolimus) - Medicaid - Effective Date 02/01/2025
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Bixiye
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023